2 3 n o v e m b e r 2 0 1 7 | v o L 5 5 1 | n A T U r e | 5 2 1 LeTTer Glycosylation is a fundamental cellular process that, in eukaryotes, occurs in the lumen of both the Golgi apparatus and the endoplasmic reticulum 1 . Nucleotide sugar transporters (NSTs) are an essential component of the glycosylation pathway, providing the diverse range of substrates required for the glycosyltransferases 2,3 . NSTs are linked to several developmental and immune disorders in humans, and in pathogenic microbes they have an important role in virulence 4-8 . How NSTs recognize and transport activated monosaccharides, however, is currently unclear. Here we present the crystal structure of an NST, the GDP-mannose transporter Vrg4, in both the substrate-free and the bound states. A hitherto unobserved requirement of short-chain lipids in activating the transporter supports a model for regulation within the highly dynamic membranes of the Golgi apparatus. Our results provide a structural basis for understanding nucleotide sugar recognition, and provide insights into the transport and regulatory mechanism of this family of intracellular transporters.
vesicles and enables the localization of Vrg4 to the Golgi membranes 17 , forms a structured region at the very C terminus. Notably, TM10 is markedly vertical with respect to the plane of the membrane, resulting in this sequence protruding above the transporter and probably aiding accessibility to the COP1 adaptor proteins 17 .
Transmembrane helices 6 and 7 (TM6-TM7) are packed against TM8-TM9 to seal a large cavity from the cytoplasm, whereas TM1-TM2 and TM3-TM4 are opened out, providing a snapshot of the transporter in the state that is closed to the cytoplasm and open to the lumen of the Golgi (Fig. 1c ). The central cavity is positively charged, suggestive of a potential site for sugar and phosphate binding. To analyse the substrate specificity, Vrg4 was reconstituted into proteoliposomes. The reconstituted protein acts as a strict antiporter 18 requiring either GDP-mannose or GMP to function, with poor transport observed with AMP, and no appreciable transport with CMP, which contains the pyrimidine base cytosine (Fig. 1d ). Our assays show that the central binding site can discriminate between mono-, di-and triphosphates (Extended Data Fig. 1c, d) . Notably, we found that the transport rate was faster when GDP-mannose, as opposed to GMP, was used on the inside of the liposome (Fig. 1e ), suggesting a potential asymmetry within the transport mechanism.
The Golgi is known to have a different lipid composition in comparison to the plasma membrane, giving rise to a thinner bilayer 19 . On reconstitution into different lipid vesicles we observed a marked effect on transport function (Fig. 1f ), highlighted by a severe reduction in transport with vesicles composed of pure POPE:POPG (3:1) lipids compared to yeast polar lipids (YPL). POPE:POPG mixtures have been extensively used to characterize a wide range of different membrane proteins 20, 21 , raising the question of why Vrg4 was not functional in these lipids. Phosphatidylglycerol comprises only a small percentage of the phospholipid in eukaryotes 22 . First we addressed whether the lack of activity seen in POPE:POPG was due to the lack of phosphatidylcholine, the major structural lipid in eukaryotes. However, activity was still not observed in vesicles made of pure POPC, POPC:POPE, or POPC-spiked POPE:POPG vesicles. These results rule out the requirement of a specific lipid head group. Similarly, we observed no transport upon the addition of ergosterol. Activity was observed only when the proteoliposomes contained lipids from natural sources. Therefore, we reasoned that the lack of function of Vrg4 in POPE:POPG lipids was a result of hydrophobic mismatch 23 . The 1-palmitoyl-2-oleoyl lipids consist of one 16-and one 18-carbon fatty acid. We found that the addition of myristoyl fatty acid (14 carbons) in the form of 1,2-dimyristoyl-snglycero-3-phosphocholine (DMPC) into the POPE:POPG vesicles could support the function of Vrg4 (Fig. 1f) . The Golgi occupies a central position within the secretory pathway, where it functions as a hub for vesicle trafficking. Many resident proteins are swept along the secretory pathway and require retrieval back to the Golgi complex 24, 25 . The extreme case of hydrophobic mismatch we observe for Vrg4 may reflect a mechanism within the NSTs to tightly regulate their function, ensuring maximal activity occurs only in the correct cellular context. Vrg4 displays a strong preference for purine nucleotides (Fig. 1d ). However, the binding site can clearly discriminate between GMP and AMP ( Fig. 2a ). The half-maximum inhibitory concentration (IC 50 ) value of GDP-mannose is the same as that of GMP (Extended Data Fig. 3 ). This suggests that sugar binding negates the negative effect of two free phosphates. To understand the structural basis of ligand recognition, we determined the structure of Vrg4 in complex with GDP-mannose to 3.6 Å (Extended Data Table 1 ). The nucleotide sugar binds in an extended conformation within the polar cavity observed previously ( Fig. 2b and Extended Data Fig. 4 ). Both nucleotide and sugar are accommodated within separate binding pockets at either end of the transporter, with the sugar pocket being considerably more polar compared to the nucleotide pocket. The presence of a separate sugar-binding pocket prompted us to test the recognition of different guanine-based nucleotide sugars ( Fig. 2c ). We observed a higher apparent affinity for GDP-mannose compared with GDP-fucose or GDP-glucose, supporting specific recognition of the sugar moiety.
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The nucleotide pocket is formed by side chains from TM7 and TM8, interacting via the O6 carbonyl group with Asn221 (TM7) and Ser266 (TM8) and via the N2 amine group with Asn220 (TM7) (Fig. 3a) . These specific interactions with the O6 carbonyl of the guanine ring help to explain the lower IC 50 values we observed for GMP compared to AMP, which does not contain an oxygen atom at this position. Analysis of sequence alignments between NSTs reveals that these asparagine residues are located within a conserved F 218 YNN motif, which is present only in transporters that recognize guanine-containing nucleotide sugars (Extended Data Fig. 5 ). Transport assays conducted on alanine variants of either Asn220 or Asn221 show an equal reduction in overall transport, whereas removal of both results in complete loss of function, highlighting the importance of this motif for nucleotide recognition (Fig. 3b ). By contrast, the ribose group forms interactions with side chains from both the N-and C-terminal halves of the transporter, with the O2 oxygen residing within hydrogen-bonding distance of Tyr28 (TM1), Ser269 (TM8) and Tyr281 (TM9). Whereas Tyr28 is strictly conserved and its replacement with alanine abolishes transport, Tyr281 is only semi conserved, but is generally a bulky side chain (Extended Data Fig. 5 ). Although transport was abolished in an alanine variant, Vrg4 was still functional with a phenylalanine substitution at this position, suggesting that a bulky side chain is required to optimally position the ribose group and/or the nearby conserved Tyr28 (Fig. 3b ). The first phosphate is positioned close to a conserved methionine, Met35 (TM1), whereas the second phosphate is seen to interact with a conserved lysine, Lys289 (TM9). Lys289 forms part of the previously identified G 285 ALNK motif, which was predicted to interact with the substrate 26 . Our structure reveals that this residue interacts with both the beta-phosphate and the glycosidic-bond oxygen. Both Lys289Ala and Gly285Ala reduced activity, although the replacement of the lysine was more severe (Fig. 3b ). Disruption of either site specifically reduces the affinity for GDP-mannose, whereas the affinity for GMP is unchanged, supporting the involvement of this motif in sugar recognition ( Fig. 3c ). The other side of the pocket is constructed from TM4, which contributes a conserved tyrosine, Tyr114, which makes a hydrogen bond to the C2 hydroxyl on the mannose ring. Although a tyrosine at this position is present in the majority of GDP-sugar transporters, it is replaced by a glutamine in the Leishmania proteins (Extended Data Fig. 5 ). A Tyr114Phe variant displayed reduced transport, highlighting the importance of a hydrogen-bond donor at this position (Extended Data Fig. 6 ).
Using the crystal structure of Vrg4, we made homology models of the human GDP-fucose (SLC35C1) and the CMP-sialic acid (SLC35A1) transporters (Extended Data Fig. 7 ). The homology model of the human GDP-fucose transporter shows the position of the conserved FYNN motif on TM7 that would coordinate the guanine ring. The main difference, as expected, is within the sugar pocket, where the GALNK motif is replaced by GTAKA, which is conserved amongst GDP-fucose transporters (Extended Data Fig. 5 ). Mutations that result in leukocyte adhesion deficiency II are Arg147Cys and Thr308Arg 4, 8, 27 . Thr308 is located on the same helix as the GTAKA motif and packs against TM10, whereas Arg147 is equivalent to Lys118 in Vrg4, and resides close to the sugar binding site. It seems likely that these disease mutations result in disruption of the sugar binding site in the GDP-fucose transporter, highlighting its importance for recognition of the sugar moiety.
In order to shuttle ligands across the membrane, solute carriers use a general alternating-access mechanism 28 . Many transporters contain symmetrically arranged structural repeats that are inverted relative to one another in the plane of the membrane 29, 30 . Specific interactions between these repeats and the ligand(s) are formed and broken, allowing for their rearrangement and facilitating transport across the membrane. Vrg4 contains two inverted repeats, TM1-TM5 and TM6-TM10 (Extended Data Fig. 8 ). In the current structure, interactions are observed between these repeats in the vicinity of the bound ligand, specifically Ser32 (TM1) and Lys289 (TM9) and Asn191 (TM6) and Lys118 (TM4); all of these residues are conserved ( Fig. 4a and Extended Data Fig. 5 ). We generated a cytoplasmic-facing model to investigate the structural changes that facilitate transport. The axis on which the transporter alternates between Golgi-and cytoplasmic-facing states runs through the observed interaction network and results in TM1 and TM3 packing together and TM6 and TM8 moving apart, opening the binding site to the cytoplasm (Fig. 4a ). Supporting the involvement of the interaction network in transport, we found that alanine variants of these residues severely reduced activity ( Fig. 4b) , whereas a conserva tive substitution of Lys118 to arginine retained approximately 50% activity, indicating the importance of a positive charge on TM4.
A key feature of any transporter is the coupling between substrate binding and conformational rearrangement. In Vrg4, the bound GDP-mannose spans the binding site interacting with TMs from both repeats, facilitating substrate-induced reorientation. If we model GMP into the nucleotide-binding pocket on TM7, the phosphate resides close to Lys118 (TM4), possibly explaining the necessity of a positive charge at this position. The ribose would make similar interactions with the tyrosine on TM1 and the serine on TM8, thereby coordinating movements between the two inverted-topology repeats.
Taken together, these insights suggest a model for transport within NSTs. In the cytoplasmic-facing state, binding of the nucleotide sugar via the two specificity pockets triggers the reorganization of the invertedtopology repeats, resulting in formation of the Golgi open state ( Fig. 4c ). Disassociation of the nucleotide sugar would vacate the binding site for the nucleotide monophosphate to bind, triggering reorientation back to the cytoplasmic state ( Fig. 4d ). This mechanism contains an inherent asymmetry, with the nucleotide sugar making more interactions with the transporter than the nucleotide monophosphate. This may explain the rate difference we observed in Vrg4 for GDP-mannose versus GMP (Fig. 1e ). In the cellular context, where both GDP-mannose and GMP are present in the cytoplasm, this asymmetry may facilitate GDP-mannose import in preference to GMP, as GDP-mannose is more effective in reorientating the transporter, resulting in preferential nucleotide sugar import into the Golgi.
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MethOdS
Cloning, expression and purification of Vrg4. The gene encoding VRG4 was amplified from Saccharomyces cerevisiae genomic DNA and cloned into a modified form of a C-terminal GFP His fusion yeast expression vector 31 . Wild-type and mutant forms of Vrg4 were expressed by growing an overnight culture in medium minus leucine with 2% glucose. This culture was diluted tenfold in medium minus leucine with 2% lactate in a 15-l fermentation vessel; after 24 h, expression was induced thorough the addition of 1.5% galactose from a 25% (w/v) stock. The yeast was collected after a further 24 h and membranes were prepared. Vrg4 and mutants were purified to homogeneity (Extended Data Fig. 9 ), using standard immobilized metal-affinity chromatography protocols in n-dodecyl-β -d-maltopyranoside (DDM) detergent (Glycon) as described previously 32 . The protein was concentrated to 40 mg ml −1 for crystallization. For functional characterization, the detergent was exchanged through size-exclusion chromatography using a Superdex 200 (10/300) SEC column to 0.3% n-decyl-β -d-maltopyranoside (DM). Crystallization and structure determination. The protein-laden mesophase was prepared by homogenizing monoolein (Sigma) and 40 mg ml −1 protein solution in a 60:40 ratio by weight using a dual-syringe mixing device at 20 °C 33 . Crystallization was carried out at 4 °C in 96-well glass sandwich plates with 50 nl mesophase and 0.8 μ l precipitant solution. The crystallization solution consisted of 26-30% (v/v) PEG 400, 0.1 M sodium citrate pH 5.0 and 75 mM sodium chloride or sodium acetate. Crystals grew within four days and reached a maximum size of 30 μ m × 5 μ m. Wells were opened using a tungsten carbide glasscutter and the crystals were collected using 30-50 μ m micromounts (MiTeGen). Crystals were cryo-cooled directly in liquid nitrogen. Heavy-atom screening was carried out by soaking the crystals in situ with 1-5 mM heavy-atom salts following manual removal of the glass cover plate followed by resealing using a glass coverslip. Successful mercury derivatives were obtained using 5 mM methylmercury chloride and soaking for 24 h. More than 200 complete datasets were collected before phases were successfully determined using long wavelength anomalous dispersion. Diffraction data for native crystals were collected at microfocus beamlines I24 (Diamond Light Source, UK), Proxima 2-A (Soleil, France) and BL1-A (Photon Factory, Japan). Data were processed and scaled using the Xia2 34 pipeline to XDS 35 and AIMLESS 36 . The space group was initially determined to be P2 1 2 1 2 with 57% non-protein content. Crystals routinely diffracted between 2.8 and 3.5 Å maximum resolution.
Following an extensive screen of heavy atoms at the I24 beamline, phases were finally calculated using data collected at BL1-A, using long-wavelength anomalous dispersion at 2.7 Å. The anomalous component of the atomic scattering factor for mercury is larger at longer wavelengths, resulting in a larger value of f″ and therefore a stronger anomalous signal. The successful dataset used for phasing (Hg/S-SAD; Extended Data Table 1 ) was the result of merging and scaling data from seven different crystals, each containing 360° of data collected on a single-axis goniometer and measured using an Eiger detector (DECTRIS). Mercury and sulfur sites were found using HySS 37 and phases were calculated using the 'extreme density modification' function, as implemented in RESOLVE. The resulting maps were of excellent quality, allowing for all ten helices from two molecules in the asymmetric unit to be observed clearly. A second, higher-resolution dataset processed to 3.2 Å resolution was used to verify the correct register of the structure (S-SAD). The mercury-soaked crystals were not isomorphous with the native crystals, preventing the use of the higher-resolution data during the initial phase calculations. In the crystal structure, we observed that four out of the eight molecules formed dimers (Extended Data Fig. 2) , as determined by the PDBePISA server (http://www.ebi. ac.uk/pdbe/pisa/). GDP-mannose was soaked into the crystals using a similar procedure to the heavy-atom soaking. In short, the top glass plate was removed using a glass scribe followed by the application of 2 μ l of crystallization solution containing 20 mM GDP-mannose. The well was resealed using a thin glass coverslip and left overnight. Crystals were using 30 μ m micromounts before flash cooling in liquid nitrogen. Model building and refinement. An initial Cα model was built into the density using O and Coot 38 . Refinement of the model was initially carried out in Phenix in space group P2 1 2 1 2. However, failure to observe a drop in the crystallographic R factors from ~ 40% prompted us to consider twinning within the crystals. Subsequent reprocessing of the data in P1, followed by molecular replacement to locate the eight molecules in the unit cell confirmed the crystals were pseudo-merohedrally twinned, with an apparent higher symmetry of P2 1 2 1 2. Fortunately, the twinning in this case actually facilitated the location of the heavy atoms in the higher-symmetry space group. The crystal structure was only fractionally divergent from the twin operator; this was large enough to make refinement of the crystal structure stall, but small enough to be accommodated within the heavy-atom refinement within HySS. The high-resolution S-SAD dataset (Extended Data Table 1 ) was reprocessed in P1, resulting in a slightly lower resolution of 3.22 Å (apo, Extended Data Table 1 ). Subsequent refinement of the eight molecules was continued in P1 with non-crystallographic symmetry restraints applied in Phenix and manual building in Coot. A final round of refinement was carried out using Buster 39 , resulting in the R factors reported in Extended Data Table 1 . Transport assays. Vrg4 was reconstituted into liposomes using the dilution method 20 . Chloroform was removed from the yeast polar lipids (Avanti polar lipids) through the use of a rotary evaporator to obtain a thin film. The lipids were washed twice in pentane and then resuspended at 5 mg ml −1 in lipid buffer (20 mM HEPES pH 7.5, 100 mM KCl). These lipid vesicles were frozen and thawed twice in liquid nitrogen and stored at − 80 °C until required. For reconstitution, the lipids were thawed and then extruded first through a 0.8-μ m filter and then through a 0.4-μ m filter. Purified Vrg4 in DM (at 0.5 μ g μ l −1 concentration) was added to the lipids at a final lipid:protein ratio of 80:1 and incubated for 1 h at room temperature, then for a further 1 h on ice; for the no-protein liposome control, the same volume of gel filtration buffer containing 0.3% DM was added. After this time, the protein-lipid mix was diluted rapidly into 65 ml of assay buffer (20 mM HEPES pH 7.5, 50 mM KCl, 2 mM MgSO 4 ) and proteoliposomes were collected through centrifugation at > 200,000g for 2 h. To remove trace detergent the proteoliposomes were dialysed overnight against a large volume of assay buffer. After dialysis, the proteoliposomes were collected and resuspended in assay buffer to a final protein concentration of 0.25 μ g μ l −1 , and then subjected to three rounds of freeze-thawing in liquid nitrogen before storage at − 80 °C. The amount of protein (both wild-type and mutant variants) reconstituted into the lipids was quantified by SDS-PAGE and densitometry (Extended Data Fig. 9 ).
To analyse transport activity, proteoliposomes were thawed and the desired concentration of internal substrate was added. To load the liposomes, they were subjected to six rounds of freeze-thaw in liquid nitrogen and then extruded through a 0.4-μ m membrane. The equivalent of 4 μ g of protein was added to 50 μ l of assay buffer containing 0.5 μ M 3 H-GMP, which initiated the transport. The uptake of radiolabelled substrate was stopped at the desired time by rapidly filtering onto 0.22-μ m filters, which were then washed with 2 × 2 ml cold water. For the timecourse experiments shown in Fig. 1e , the equivalent of 0.5 μ g of protein was used per time point and a total of 20 μ M GMP as substrate on the outside of the vesicles was used.
The amount of GMP transported inside the liposomes was calculated by scintillation counting in Ultima Gold (Perkin Elmer). Experiments were performed a minimal of four times to generate an overall mean and s.d. Lipid specificity. Wild-type Vrg4 was reconstituted into a range of different lipid vesicles. The lipids used were either YPL, E. coli polar lipids, 1-palmitoyl-2oleoyl-sn-glycero-3-phosphocholine (POPC, Avanti Polar Lipids), or a 3:1 ratio of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine:1-palmitoyl-2-oleoyl-snglycero-3-phosphoglycerol (POPE:POPG), POPC:POPE, or soy phosphatidylethanolamine (PE):egg phosphatidylglycerol (PG); or a 3:1 ratio of POPE:POPG with 12% ergosterol, POPC, egg phosphatidylcholine (PC), YPL or DMPC added. All lipid vesicles were prepared as described in the section 'Transport assays' , and wild-type Vrg4 was reconstituted at an 80:1 total lipid-to-protein ratio as described. Transport was assessed using 4 μ g of protein per time point taken and 20 μ M GMP as substrate on the outside and 1 mM GDP-mannose on the inside of the vesicles, or water as a negative control. Transport was monitored over 10 min, and Fig. 1f shows the relative uptake in comparison to yeast polar lipids at 5 min for each lipid type used. Experiments were performed a minimum of four times from two separate reconstitutions to generate an overall mean and s.d. Data availability. Atomic coordinates for the atomic models have been deposited in the Protein Data Bank (PDB) under accession numbers 5OGE (apo structure of Vrg4) and 5OGK (GDP-mannose-bound Vrg4). The expression plasmid has been deposited in Addgene, with ID 102334 (https://www.addgene.org/102334/).
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Extended Data Figure 1 | Analysis of anomalous difference electron density and substrate specificity and recognition by Vrg4. a, Anomalous difference peaks for the mercury (orange mesh) and sulfur (green mesh) atoms calculated using AnoDe and contoured at 3σ, and overlaid on the structure of Vrg4. b, Final refined 2mF o − DF c maps for Vrg4, contoured at 1σ. TM10 is highlighted along with side-chain density. c, Transport cannot be driven by GTP in the presence or absence of CCCP (C) or valinomycin (v). n = 4 independent experiments, data are mean ± s.d. d, Competition assays demonstrate that GMP and GDP-mannose act as the most effective competitors of transport, but other guanosine-containing substrates (GDP, GDP-fucose, GDP-glucose) can also compete and be recognized by the binding site. However, the free base guanosine is very poorly recognized, as is cGMP. Pyrophosphate, which consists of a diphosphate moiety and is an inhibitor of ATPases, cannot inhibit the transport activity of Vrg4. n = 4 independent experiments, data are mean ± s.d.
Extended Data Figure 2 | Lipid molecules are found at the dimer interface of Vrg4. a, The eight molecules in the P1 unit cell are shown, four of which adopt a dimer arrangement with the monomers arranged in a physiological orientation. Several lipid molecules could be identified and are shown in blue. b, Zoomed-in view of the Vrg4 dimer showing the electrostatic surface of the dimer interface between helices 5 and 10 and the two monoolein lipids bound. The hydrophobic belt is noticeably shorter (~ 30 Å) than that observed for plasma or inner membrane transporters (~ 40 Å). Within the dimer interface, the two well-ordered monoolein molecules contribute ~ 60% to the total buried surface area of 1,514 Å 2 . In the remaining four monomeric molecules in the unit cell we do not observe any density for lipid molecules at these sites, suggesting an important role for lipid-mediated dimerization. c, Refined 2mF o − DF c electron density for the lipid molecules shown in b, present in the apo crystal structure. d, The dimer-interface lipids were more ordered in the GDP-mannose soaked crystals. All electron density maps are contoured at 1σ. 

Extended Data Figure 9 | Analysis of purified Vrg4 in both detergent and lipid environments. a, Representative gel filtration trace of the purified Vrg4 in the detergent decylmaltoside which was used for reconstitution, n = 20. The protein elutes as a single peak and is purified to homogeneity as judged by Coomassie-stained SDS-PAGE, in which it runs as a single band at ~ 30 kDa. b, Size-exclusion chromatography with multiangle static light scattering analysis indicates that Vrg4 is monomeric in decylmaltoside with an expected mass of 37 kDa (the refractive index increment (dn/dc) values for protein and decylmaltoside detergent used were 0.185 and 0.147, respectively). n = 3 independent experiments, producing similar results. c, Representative SDS-PAGE gel showing reconstitution of Vrg4 into different lipid environments. The same amount of protein was used for each lipid type tested: YPL, POPE:POPG (in a 3:1 ratio), soy PE:egg PG (in a 3:1 ratio), POPE:POPG and POPC (a 3:1 ratio of POPE:POPG with 12% POPC added), POPE:POPG and DMPC (a 3:1 ratio of POPE:POPG with 12% DMPC added). n = 5 independent experiments, producing similar results. The asterisk shows the presence of a protein band (a dimer in size) observed upon reconstitution into liposomes, which is not seen when the protein is in detergent (a, inset) but is observed in the unit cell of the crystal structure. d, Representative gelfiltration profiles of all the mutants used in this study, n = 2 independent experiments, producing similar results. The traces show that all mutant variants behave similarly to wild-type protein during purification, showing monodisperse peaks with little aggregation. With relation to the differing amounts of protein shown in these graphs, this is owing to the different volumes used to express the protein (either > 10 l for the upper two panels or 5 l for the lower panel). e, Representative SDS-PAGE gel showing reconstitution of Vrg4 and the mutant variants used in this study, showing that the same amount of protein was used in the assays. n = 3 independent experiments, producing similar results. Corresponding author(s): Simon Newstead
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Data exclusions
Describe any data exclusions. No data were excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
All biochemical assays were repeated a minimum of three times and were reproducible.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Samples were not randomized for the experiments as this was not applicable for the biochemical assays described in our study.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was applied to the data generated in our study, as this is not applicable to the types of biochemical or structural data generated.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
